Overview

The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the clinical effects of coenzyme Q10 and Curcumin in improving the cytopenias of patients with myelodysplastic syndromes. we propose to explore the efficacy of the natural compounds curcumin and CoQ10 in MDS because these two agents possess many of the effects that are desirable in MDS.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Coenzyme Q10
Curcumin
Ubiquinone